Immuron Ltd (IMRN) stock
IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
$0.87−0.03 (-3.20%)
Close on Nov 17, 2026Market cap $7.03MP/E –Yield –
Immuron price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Immuron's price to sales ratio was 1.3× on Nov 11, 2026, against 2.1× a year earlier. Over the last 5 years it ranged from 0.0× to 24.2×, with a median of 3.2×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.3× | +0.4 |
| 2025 | Dec 31, 2025 | 0.9× | −2.3 |
| 2024 | Dec 31, 2024 | 3.2× | +3.2 |
| 2023 | Dec 29, 2023 | 0.0× | −22.7 |
| 2022 | Dec 30, 2022 | 22.7× | +11.2 |
| 2019 | Jul 31, 2019 | 11.6× | −6.8 |
| 2018 | Dec 31, 2018 | 18.4× | +8.7 |
| 2017 | Dec 29, 2017 | 9.7× | −0.4 |
| 2016 | Dec 30, 2016 | 10.1× | – |
See a number that looks wrong?